phase readout
saveNCT07160725: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Solid Tumours
view source ↗
comments(0)
5-min edit window · permanent after that